AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines. AstraZeneca generated global revenues of US $32.8 billion in 2009.

AstraZeneca sought to enhance patient safety and protect brand integrity through serialisation, as part of a comprehensive product security strategy. “We needed a solution that would be flexible and adaptable to fit with our approach,” said Christoph Krähenbühl, IS Programme Manager, Pack Coding and Product Security at AstraZeneca Global Operations Information.

Axway Track & Trace is now the key component of AstraZeneca’s systems-based product security approach. “As Axway’s solution has evolved, the new version enables us to benefit from moving to the GS1 standards-based system (EPCIS) that reduces the cost and complexity of complying with regulations,” said Krähenbühl, “and fits in with our desire to remain compliant with external standards.”